Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FibroMAX™: towards a new universal biomarker of liver disease?

1 Sept 2007

Abstract excerpt

Among the noninvasive alternatives to liver biopsy, several studies have demonstrated the predictive value and a better benefit-to-risk ratio than biopsy of five combinations of simple serum biochemical markers (the super combination being FibroMAX (BioPredictive, Paris, France) in patients at risk of chronic liver diseases: FibroTest (BioPredictive) for the quantitative assessment of fibrosis; SteatoTest...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Liver Disease and Transplantation
Share to Liver Disease Diagnosis and Treatment
Share to Liver Diseases and Immunity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17892356
DOI: 10.1586/14737159.7.5.481

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FibroMAX™: towards a new universal biomarker of liver disease?PMID 17892356Read ↗

The Nimble Stage 1 Study Validates Diagnostic Circulating Biomarkers for Nonalcoholic SteatohepatitisSemantic proximity Read ↗

Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods.Semantic proximity Read ↗

FIB-4 First in Diagnostic Algorithm of MAFLD at the Era of “Global Metabodemic “Semantic proximity Read ↗

Support of precision medicine through risk-stratification in autoimmune liver diseases - histology, scoring systems, and non-invasive markers.Semantic proximity Read ↗

Current Insights into Liver Fibrosis: Epidemiological Patterns, Etiopathogenesis, Clinical Correlates, and Research AgendaSemantic proximity Read ↗

Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.Semantic proximity Read ↗

The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis.Semantic proximity Read ↗

Affinity proteomics-based non-invasive detection of clinically significant liver diseaseSemantic proximity Read ↗

A blood-based biomarker panel for non-invasive diagnosis of metabolic dysfunction-associated steatohepatitisSemantic proximity Read ↗

Tools for the diagnosis of hepatitis C virus infection and hepatic fibrosis staging.Semantic proximity Read ↗

How Effective Are Serum Scoring Systems in Predicting Liver Fibrosis Caused by Chronic Hepatitis B? Serum Scoring Systems and Liver FibrosisSemantic proximity Read ↗

Diagnosis and Staging of Metabolic Dysfunction-Associated Steatotic Liver Disease Using Biomarker-Directed Aptamer PanelsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.